The focus is on a drug called Lepodisiran, that could target certain factors that increase risk of heart attacks and strokes.

Cardiovascular disease (CVD) is the leading cause of death worldwide. According to the Global Burden of Disease study, which compiles and analyzes population health data from 204 countries, the number ...

Cardiovascular Disease is the leading cause of death worldwide, accounting for 31% of all deaths. It is a global health priority that will grow with ageing populations. Cardiovascular Disease is the ...

A new article proposes offering citizens over 50 a combined medication that includes a cocktail of blood pressure-lowering ...

A University of Iowa-led research team has found that urinary incontinence may be associated with a greater risk of ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn to neglected area.

The basic research encompasses integrative aspects of cardiovascular structure-function, studying the functional relationships between intercellular and extracellular mechano-transduction signaling.

Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.

The Baylor College of Medicine Research Training Program in Cardiovascular Research and Drug Development is designed to prepare Ph.D. students for a research career in cardiovascular research in ...

Large animal models are pivotal in the realm of preclinical cardiovascular research, offering critical insights that bridge foundational scientific ...

Hormone therapy has long been prescribed to relieve bothersome menopausal symptoms, but research published in 2002 and 2004 ...

Cardiovascular research is one of the key areas of interest of the Department of Molecular Physiology and Biophysics. Research by our faculty members focuses on a variety of subjects including ...